Publication | Open Access
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study
23
Citations
11
References
2020
Year
Platinum-resistant/refractory Ovarian CancerMedicineCancer ManagementPharmacologyTamrintamab PamozirineGynecologyPharmacotherapyCancer TreatmentOncologyPhase 1Endocrine-related CancerOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1